You have successfully subscribed the newsletter.
USFDA issues CRL for proposed biosimilar Insulin-R: Biocon
Biotechnology major Biocon on Saturday said the US health regulator has issued a complete response letter for Biocon Biologics' application for Insulin-R, a pr...
Another Alzheimer’s drug fails in late-stage trials – what now?
Back home from drug rehab Delhi man kills parents, grandmother, …
Zydus Lifesciences gets USFDA nod to sell its cancer medicine in…
Cipla gets USFDA nod for cancer drug
Bayer introduces medication for chronic kidney disease
Intercept Pharmaceuticals settles Ocaliva patent litigation case…
Commerce ministry for imposing anti-dumping duty on Chinese oflo…
AstraZeneca India receives DCGI's nod to market drug treating br…
Strides Pharma Science arm gets USFDA nod for generic naproxen s…
Share this article
If you liked this article share it with your friends.
they will thank you later